Evidence map›Paper›PMID 25033463›Full record

ArticlePLoS pathogens2014

LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex.

Jianhong Hu, Yajie Yang, Peter C Turner, Vaibhav Jain, Lauren M McIntyre, Rolf Renne

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jianhong HuDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Yajie YangDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Peter C TurnerDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Vaibhav JainDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Lauren M McIntyreDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America; UF Genetics Institute, University of Florida, Gainesville, Florida, United States of America.
Rolf RenneDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America; UF Genetics Institute, University of Florida, Gainesville, Florida, United States of America; UF Health Cancer Center, University of Florida, Gainesville, Florida, United States of America.
University of Florida · US

Funding

LANA AND CELLULAR GENE EXPRESSION IN KAPOSIS SARCOMAR01CA088763 · NCI · UNIVERSITY OF FLORIDA · PI RENNE, ROLF F · 2000 to 2015
$3.2M
Quantitative Comparisons between genotypes and model speciesR01GM102227 · NIGMS · UNIVERSITY OF FLORIDA · PI MCINTYRE, LAUREN M. · 2012 to 2015
$1.2M
NCI NIH HHS R01 CA088763NCI NIH HHS R01 CA88763NIGMS NIH HHS R01 GM102227
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a γ-herpesvirus associated with KS and two lymphoproliferative diseases. Recent studies characterized epigenetic modification of KSHV episomes during latency and determined that latency-associated genes are associated with H3K4me3 while most lytic genes are associated with the silencing mark H3K27me3. Since the latency-associated nuclear antigen (LANA) (i) is expressed very early after de novo infection, (ii) interacts with transcriptional regulators and chromatin remodelers, and (iii) regulates the LANA and RTA promoters, we hypothesized that LANA may contribute to the establishment of latency through epigenetic control. We performed a detailed ChIP-seq analysis in cells of lymphoid and endothelial origin and compared H3K4me3, H3K27me3, polII, and LANA occupancy. On viral episomes LANA binding was detected at numerous lytic and latent promoters, which were transactivated by LANA using reporter assays. LANA binding was highly enriched at H3K4me3 peaks and this co-occupancy was also detected on many host gene promoters. Bioinformatic analysis of enriched LANA binding sites in combination with biochemical binding studies revealed three distinct binding patterns. A small subset of LANA binding sites showed sequence homology to the characterized LBS1/2 sequence in the viral terminal repeat. A large number of sites contained a novel LANA binding motif (TCCAT)3 which was confirmed by gel shift analysis. Third, some viral and cellular promoters did not contain LANA binding sites and are likely enriched through protein/protein interaction. LANA was associated with H3K4me3 marks and in PEL cells 86% of all LANA bound promoters were transcriptionally active, leading to the hypothesis that LANA interacts with the machinery that methylates H3K4. Co-immunoprecipitation demonstrated LANA association with endogenous hSET1 complexes in both lymphoid and endothelial cells suggesting that LANA may contribute to the epigenetic profile of KSHV episomes.

Indexed as

Chromatin Assembly and DisassemblyResponse ElementsAntigens, ViralEpigenesis, GeneticHEK293 CellsHerpesvirus 8, HumanHistone-Lysine N-MethyltransferaseHumansMethylationNuclear ProteinsPlasmidsSarcoma, KaposiTranscription, GeneticAntigens, ViralHistone-Lysine N-Methyltransferaselatency-associated nuclear antigenNuclear ProteinsSetd1A protein, human

Identifiers

PMID25033463
PMCPMC4102568
OpenAlexW2037504547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.